Manipal Hospitals implants AI-driven wireless injectable pacemaker
Marking a significant advancement in cardiac care, Manipal Hospitals has successfully implanted an AI-driven, wireless injectable pacemaker, the Aveir Leadless pacemaker, developed by Abbott. This milestone makes Manipal Hospital, Dhakuria, the first center in Eastern India to perform the procedure, with the inaugural implant in a 65-year-old patient.
The innovative device, recently introduced to the Indian market, offers a less invasive alternative to traditional pacemakers, already in use in the United States and Europe. Its small size, weighing just 2.4 grams, and long lifespan of 20-25 years, nearly three times longer than conventional models, reduce the need for frequent replacements. Dr. P.K. Hazra, Interventional Cardiologist at Manipal Hospital, highlighted the device’s upgradeable feature, which allows for a switch from single to dual-chamber configurations, enhancing its versatility for patients. The pacemaker also boasts Bluetooth technology for remote monitoring, minimizing hospital visits.
Following the initial procedure, two more implants were conducted at Medica Superspecialty Hospital and Manipal, Mukundapur. This groundbreaking innovation is expected to benefit patients in Nepal, where cardiovascular diseases are a leading cause of mortality, by providing access to advanced cardiac care closer to home. Experts emphasize the device’s minimally invasive nature, making it ideal for patients with compromised immunity or conditions that complicate traditional surgeries. As India becomes the third country to adopt this technology, it opens new possibilities for effective cardiac care in the region.
